Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
Abroad (travel likely)Recruiting
Conditions
Melanoma Stage IV · Melanoma Stage III · Immunotherapy · Toxicity, Drug
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Erasmus MC, Rotterdam, Netherlands
Contact: Study coordinator (Astrid A.M. van der Veldt, Dr.) · a.vanderveldt@erasmusmc.nl · +31107041754